C3.ai ($AI) Misrepresentation of Growth Outlook and Leadership Stability Case

The court has appointed the lead plaintiff to represent the class.

N.D. California

Court

3:25‑cv‑07129

Case number

02/26/2025

Class period Start

08/08/2025

Class period End

10/21/2025

Lead Plaintiff motion deadline

$AI investors filed a claim against C3.ai for misrepresenting its growth outlook, concealing the impact of CEO Thomas Siebel’s health problems on deal execution, and overstating revenue prospects.
After reporting preliminary Q1 2026 results far below expectations and cutting full-year guidance, $AI collapsed 25.58%, on August 8 to August 11, 2025.
$AI investors can join this case to be notified about potential recovery.
Case Details:

Between February 26, 2025, and August 8, 2025, C3.ai and its executives assured investors that CEO Thomas Siebel remained fully capable of leading the business despite his health issues and repeatedly emphasized strong market demand, revenue momentum, and long-term growth potential. The company also provided guidance projecting revenue between $447.5 million and $484.5 million for fiscal 2026.

In reality, Siebel’s health struggles, including hospitalizations and vision impairment, were limiting his ability to close sales, while C3.ai’s sales execution faltered. These risks were downplayed or concealed as management portrayed a picture of stability and resilience.

The truth emerged on August 8, 2025, when C3.ai disclosed preliminary Q1 2026 revenue of just $70.2–70.4 million, far below its own guidance of up to $109 million. The company cut its full-year revenue outlook, attributing the weakness to Siebel’s health issues and a disruptive sales reorganization. The stock fell 25.58% over the next trading session.

Based on these events, $AI investors filed a claim against C3.ai, alleging the company:
It misrepresented CEO Siebel’s health and its impact on operations.
It concealed weaknesses in its sales execution and forecasting processes.
It artificially inflated its stock price with overly optimistic revenue guidance.
Investors argue C3.ai misled the market about its ability to execute growth while downplaying the risks tied to leadership stability and operational performance.

Case Type

US Securities Class Action

Case Status

Lead Plaintiff Appointed

Alleged Offence

Misleading Statements,

Financial Misrepresentation,

Fraud

Suspected Party

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

08/08/2025

Filing date

08/22/2025

Lead Plaintiff Deadline

10/21/2025

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.